Pharmacogenomics of anticoagulants: steps toward personal dosage

le Daly, Ann K
Foilsithe 2009

Pharmacogenomics of adverse drug reactions

le Daly, Ann K
Foilsithe 2013

Are Polymorphisms in Genes Relevant to Drug Disposition Predictors of Susceptibility to Drug-Induced Liver Injury?

le Daly, Ann K.
Foilsithe in Pharm Res (2016)

Opportunities and limitations: the value of pharmacogenetics in clinical practice

le Daly, Ann K, Cascorbi, Ingolf
Foilsithe 2014

The kinetic mechanism of the major form of ox kidney aldehyde reductase with d-glucuronic acid

le Daly, Ann K., Mantle, Timothy J.
Foilsithe 1982

CYP3A5 phenotype-genotype correlations in a British population

le Daly, Ann K, King, Barry P
Foilsithe 2004

Candidate gene case-control association studies: advantages and potential pitfalls

le Daly, Ann K, Day, Christopher P
Foilsithe 2001

CYP2C9 polymorphism and warfarin dose requirements

le Daly, Ann K, Day, Christopher P, Aithal, Guruprasad P
Foilsithe 2002

The effect of NAT2 genotype and gender on the metabolism of caffeine in nonsmoking subjects

le Welfare, Mark R, Bassendine, Margaret F, Daly, Ann K
Foilsithe 2000

CYP2D6 and CYP2C19 genotypes of patients with terodiline cardiotoxicity identified through the yellow card system

le Ford, Gary A, Wood, Susan M, Daly, Ann K
Foilsithe 2000

Pharmacogenomics of CYP2C9: Functional and Clinical Considerations(†)

le Daly, Ann K., Rettie, Allan E., Fowler, Douglas M., Miners, John O.
Foilsithe in J Pers Med (2017)

CYP3A5 phenotype-genotype correlations in a British population

le King, Barry P, Leathart, Julian B S, Mutch, Elaine, Williams, Faith M, Daly, Ann K
Foilsithe 2003

Endocytosis and Lack of Cytotoxicity of Alkyl-Capped Silicon Quantum Dots Prepared from Porous Silicon

le Phatvej, Wipaporn, Datta, Harish K., Wilkinson, Simon C., Mutch, Elaine, Daly, Ann K., Horrocks, Benjamin R.
Foilsithe in Materials (Basel) (2019)

Next-Generation Sequencing of PTGS Genes Reveals an Increased Frequency of Non-synonymous Variants Among Patients With NSAID-Induced Liver Injury

le Lucena, María Isabel, García-Martín, Elena, Daly, Ann K., Blanca, Miguel, Andrade, Raúl J., Agúndez, José A. G.
Foilsithe in Front Genet (2019)

Paracetamol metabolism, hepatotoxicity, biomarkers and therapeutic interventions: a perspective

le Athersuch, Toby J., Antoine, Daniel J., Boobis, Alan R., Coen, Muireann, Daly, Ann K., Possamai, Lucia, Nicholson, Jeremy K., Wilson, Ian D.
Foilsithe in Toxicol Res (Camb) (2018)

Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon

le Verhoef, Talitha I, Redekop, William K, Daly, Ann K, van Schie, Rianne M F, de Boer, Anthonius, Maitland-van der Zee, Anke-Hilse
Foilsithe 2014

Gene polymorphisms of cellular senescence marker p21 and disease progression in non-alcohol-related fatty liver disease

le Aravinthan, Aloysious, Mells, George, Allison, Michael, Leathart, Julian, Kotronen, Anna, Yki-Jarvinen, Hannele, Daly, Ann K, Day, Christopher P, Anstee, Quentin M, Alexander, Graeme
Foilsithe 2014

Adaptive dosing approaches to the individualization of 13-cis-retinoic acid (isotretinoin) treatment for children with high-risk neuroblastoma

le Veal, Gareth J., Errington, Julie, Rowbotham, Sophie E., Illingworth, Nicola A., Malik, Ghada, Cole, Michael, Daly, Ann K., Pearson, Andrew D.J., Boddy, Alan V.
Foilsithe 2012

A multi-factorial analysis of response to warfarin in a UK prospective cohort

le Bourgeois, Stephane, Jorgensen, Andrea, Zhang, Eunice J., Hanson, Anita, Gillman, Matthew S., Bumpstead, Suzannah, Toh, Cheng Hock, Williamson, Paula, Daly, Ann K., Kamali, Farhad, Deloukas, Panos, Pirmohamed, Munir
Foilsithe in Genome Med (2016)

The population pharmacokinetics of R- and S-warfarin: effect of genetic and clinical factors

le Lane, Steven, Al-Zubiedi, Sameh, Hatch, Ellen, Matthews, Ivan, Jorgensen, Andrea L, Deloukas, Panos, Daly, Ann K, Park, B Kevin, Aarons, Leon, Ogungbenro, Kayode, Kamali, Farhad, Hughes, Dyfrig, Pirmohamed, Munir
Foilsithe 2012